Table 3:
Dosage and Duration of Opioid Prescriptions Following Dental Visits by Visit Type and Prior High Risk Prescription Use
| Day’s Supply Mean (SD) |
Quantity Prescribed Mean (SD) |
Daily MME Mean (SD) |
P-Value | |
|---|---|---|---|---|
| Overall | 3.6 (3.6) | 17.5 (13.1) | 32.1 (16.0) | |
| Visit Type | <0.05 | |||
|
Invasive Procedures |
3.4 (2.3) | 17.1 (9.5) | 32.8 (15.4) | |
| Endodontics | 3.1 (2.9) | 15.8 (12.1) | 32.0 (16.1) | |
| Periodontics | 2.6 (0.8) | 13.3 (4.5) | 31.5 (14.1) | |
| OMFS | 3.4 (2.3) | 17.1 (9.3) | 32.8 (15.3) | |
| Implants | 2.8 (0.8) | 15.9 (3.5) | 31.8 (7.3) | |
| All other invasive procedure combinations | 3.1 (1.6) | 16.9 (10.8) | 34.2 (15.5) | |
|
Non-invasive Procedures |
4.2 (5.3) | 18.3 (18.3) | 30.6 (17.1) | |
| Endodontics | 6.0 (12.2) | 23.0 (27.8) | 32.3 (17.0) | |
| Periodontics | 6.3 (8.9) | 26.8 (31.9) | 32.0 (18.5) | |
| Implants | 3.0 (N/A) | 20.0 (N/A) | 33.3 (N/A) | |
| Diagnostic | 3.8 (4.4) | 18.7 (16.4) | 35.0 (18.5) | |
| Preventive | 9.1 (11.3) | 27.2 (22.3) | 34.0 (20.0) | |
| Restorative | 5.2 (7.6) | 22.7 (25.4) | 35.2 (21.5) | |
| All other non- invasive procedure combinations |
4.2 (5.4) | 17.5 (17.8) | 28.3 (15.5) | |
| High Risk Status* | <0.05 | |||
| Yes | 4.3 (5.6) | 19.5 (19.2) | 33.6 (18.6) | |
| No | 3.3 (1.8) | 16.5 (8.1) | 31.2 (14.4) |
SD=Standard Deviation; MME: Milligram Morphine Equivalent
”Prior high risk prescription use” is defined as beneficiaries with: More than 3 prescribers within 12 months; More than 4 controlled substance II-V prescriptions within 12 months; More than 2 controlled substance II-V prescriptions within last 40 days; Any prescription for Methadone, Suboxone, Fentanyl Transdermal, Long-acting Morphine, or Long-acting Oxycodone within last 6 months; Any overlapping prescriptions for Narcotics (controlled substance II-V) and Benzodiazepines within last 6 months; More than 100 average MME/day (Morphine Milligram Equivalent/day) prescribed within last 40 days